Remove Disease Remove Medical Imaging Remove Nuclear Medicine
article thumbnail

CMS lifts limit on amyloid PET coverage

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PET scan per lifetime for patients with Alzheimer’s disease. That statement is encouraging, noted the Medical Imaging and Technology Alliance (MITA).

article thumbnail

Meet the Minnies 2024 finalists

AuntMinnie

His research interests include using structural and functional MRI -- particularly ultrahigh-field, 7-tesla MRI -- to map brain microstructure and develop neurosurgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Treatment paradigm shifting for men with prostate cancer

AuntMinnie

New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC), according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

article thumbnail

AI spots unidentified brain tumor on PET imaging

AuntMinnie

An AI algorithm designed for brain PET imaging found a glioblastoma in a patient that had gone undetected by physicians, according to a case reported February 15 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine.

article thumbnail

Generative AI, radiologist shortages feature in 2024 Minnies

AuntMinnie

Middlebrooks' research interest consists of using ultrahigh-field, 7-tesla MRI to plot brain microstructure and develop surgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia.

article thumbnail

Zukotynski receives lifetime achievement award

AuntMinnie

Katherine Zukotynski, MD, PhD, of McMaster University in Hamilton, Ontario, has been awarded the American College of Nuclear Medicines (ACNM) 2025 Lifetime Achievement Award. Image courtesy of McMaster University. Katherine Zukotynski, MD, PhD.

article thumbnail

PET tracer shows promise in prostate cancer patients

AuntMinnie

Moreover, the approach could help detect disease that other effective prostate cancer PET radiotracers may miss, said Heying Duan, MD, a nuclear medicine research scientist at Stanford University, during a November 26 scientific session. You've hear a lot about PSMA. Yet up to 10% of cases do not express PSMA, she noted.